Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 May 1;171(5):1527-33.
doi: 10.1084/jem.171.5.1527.

Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo

Affiliations

Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo

A Nagler et al. J Exp Med. .

Abstract

The majority of human NK cells express low affinity IgG Fc receptors (CD16+), whereas a minor subset of NK cells lack Fc receptor expression (CD16-). In contrast to CD16+ NK cells that express only p75 IL-2 receptors, CD16- NK cells constitutively co-express both p75 and p55 IL-2 receptors in vivo and preferentially respond to low concentrations of IL-2 with increased cytolytic activation and proliferation. Scatchard analysis demonstrated the presence of approximately 1,200 high affinity (approximately 25 pM kD) and approximately 9,600 intermediate affinity (approximately 2 nM kD) IL-2 receptors on CD16- NK cells. CD16+ NK cells expressed only a single intermediate affinity IL-2 receptor of approximately 1.9 nM kD (approximately 9,000 sites per cell). The IL-2 binding data thus substantiated the phenotypic and functional studies and definitively show that the differential responsiveness of CD16- and CD16+ NK cells to IL-2 is manifested through different affinity IL-2 receptors.

PubMed Disclaimer

References

    1. J Clin Oncol. 1987 Dec;5(12):1933-41 - PubMed
    1. J Exp Med. 1987 Oct 1;166(4):1055-69 - PubMed
    1. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1982-6 - PubMed
    1. J Immunol. 1989 Apr 15;142(8):2949-54 - PubMed
    1. J Exp Med. 1989 Jul 1;170(1):291-6 - PubMed